Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARVINAS, INC.ARVN · Entity 5355 | Director | June 25, 2025 | June 27, 2025 |
| Johnson Controls International plcJCI · Entity 2940 | Director | March 04, 2026 | March 06, 2026 |
| PFIZER INCPFE · Entity 2863 | Group President | December 15, 2021 | December 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARVINAS, INC.
Report date June 25, 2025 · Filed June 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,045 |
Reported balance
After 2025-06-25 transaction · row 1
1 source rowRow 1 · 2025-06-25 · Grant · Acquired 16,025 · Balance 26,045 F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.80 · Expires 2035-06-24 | Direct | 23,105 |
Reported balance
After 2025-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-25 · Grant · Acquired 23,105 · Balance 23,105 F2: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
F2: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
Johnson Controls International plc
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 18,271.58 |
Reported balance
After 2026-03-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-04 · Grant · Acquired 1,285 · Balance 18,271.58 F1: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,156.58 |
Reported balance
After 2026-03-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-04 · Tax withholding · Disposed 1,115 · Balance 17,156.58 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting.
PFIZER INC
Report date December 15, 2021 · Filed December 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 53,635 |
Reported balance
After 2021-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-15 · Grant · Acquired 8 · Balance 53,635 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 28,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · nonDerivative · entry 5 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,647 F5 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 26, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 39,677 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · derivative · entry 8 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,677 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Dividend equivalents are paid on these stock appreciation rights at the time of settlement. Read SEC document |
| February 26, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 44,874 | $31.99 | $1,435,519.26 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · nonDerivative · entry 4 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,513 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,642 | $31.99 | $244,467.58 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · nonDerivative · entry 3 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,387 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 16,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,029 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2014 Filed Feb 28, 2014 21:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 57,586 | $12.70 | $731,342.20 |
DisclosureSEC source: 0001225208-14-006898 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| December 31, 2013 Filed Jan 3, 2014 01:35 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 50 | $30.63 | $1,531.50 |
DisclosureSEC source: 0001225208-14-000185 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,123 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 13, 2013 Filed Dec 16, 2013 21:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 51 | $30.25 | $1,542.75 |
DisclosureSEC source: 0001225208-13-025456 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,073 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 27, 2013 Filed Dec 2, 2013 18:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 48 | $31.88 | $1,530.24 |
DisclosureSEC source: 0001225208-13-024414 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,022 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2013 Filed Nov 18, 2013 20:32 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 75 | $32.00 | $2,400.00 |
DisclosureSEC source: 0001225208-13-023753 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,986 Underlying: Common Stock · 75 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2013 Filed Nov 4, 2013 20:55 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $30.69 | $1,503.81 |
DisclosureSEC source: 0001225208-13-022773 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,911 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2013 Filed Oct 16, 2013 19:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 54 | $29.16 | $1,574.64 |
DisclosureSEC source: 0001225208-13-021917 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,862 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 14:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 52 | $28.73 | $1,493.96 |
DisclosureSEC source: 0001225208-13-020986 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,808 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 13, 2013 Filed Sep 17, 2013 16:55 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 54 | $28.51 | $1,539.54 |
DisclosureSEC source: 0001225208-13-020074 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,756 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 30, 2013 Filed Sep 4, 2013 14:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 55 | $28.21 | $1,551.55 |
DisclosureSEC source: 0001225208-13-018989 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,702 Underlying: Common Stock · 55 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2013 Filed Aug 16, 2013 19:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 54 | $28.80 | $1,555.20 |
DisclosureSEC source: 0001225208-13-017983 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2013 Filed Aug 1, 2013 21:49 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 65 | $29.23 | $1,899.95 |
DisclosureSEC source: 0001225208-13-017079 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Stock · 65 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2013 Filed Jul 16, 2013 22:44 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 53 | $28.79 | $1,525.87 |
DisclosureSEC source: 0001225208-13-016257 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,528 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 28, 2013 Filed Jul 2, 2013 13:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 55 | $28.01 | $1,540.55 |
DisclosureSEC source: 0001225208-13-015239 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Underlying: Common Stock · 55 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 14, 2013 Filed Jun 18, 2013 17:07 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 53 | $29.09 | $1,541.77 |
DisclosureSEC source: 0001225208-13-014508 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2013 Filed Jun 3, 2013 22:58 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 57 | $27.23 | $1,552.11 |
DisclosureSEC source: 0001225208-13-013714 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:21 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 62 | $29.56 | $1,832.72 |
DisclosureSEC source: 0001225208-13-012584 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2013 Filed May 1, 2013 22:29 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 53 | $29.07 | $1,540.71 |
DisclosureSEC source: 0001225208-13-010925 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 15, 2013 Filed Apr 17, 2013 12:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 51 | $30.45 | $1,552.95 |
DisclosureSEC source: 0001225208-13-010064 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,195 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:23 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 50 | $28.86 | $1,443.00 |
DisclosureSEC source: 0001225208-13-008787 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,144 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 15, 2013 Filed Mar 18, 2013 21:57 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 859 | $28.02 | $24,069.18 |
DisclosureSEC source: 0001225208-13-007886 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,094 Underlying: Common Stock · 859 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 15:29 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 14,713 | $28.13 | $413,876.69 |
DisclosureSEC source: 0001225208-13-007040 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,520 Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 100,548 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · derivative · entry 10 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,548 Underlying: Common Stock · 100,548 shares Expires 2020-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 121,145 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · derivative · entry 9 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,145 Underlying: Common Stock · 121,145 shares Expires 2018-02-28 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 23,135 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · derivative · entry 8 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,135 shares Expires 2013-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Dividend equivalents are paid on these stock appreciation rights at the time of settlement. F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 22,953 | $27.37 | $628,223.61 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · nonDerivative · entry 5 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,233 F5 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 10,495 | $27.37 | $287,248.15 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · nonDerivative · entry 4 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,186 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 20,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · nonDerivative · entry 3 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,681 F3 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 21,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,189 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2013 Filed Mar 5, 2013 01:00 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 26,871 | $22.55 | $605,941.05 |
DisclosureSEC source: 0001225208-13-006488 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| January 30, 2013 Filed Feb 1, 2013 12:45 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 26,752 | $27.65 | $739,559.04 |
DisclosureSEC source: 0001225208-13-002635 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,708 Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:12 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,875 | $25.08 | $97,185.00 |
DisclosureSEC source: 0001225208-13-000300 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,460 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| December 28, 2012 Filed Jan 2, 2013 22:56 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 59 | $24.89 | $1,468.51 |
DisclosureSEC source: 0001225208-13-000235 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233 Underlying: Common Stock · 59 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2012 Filed Dec 17, 2012 23:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 58 | $25.18 | $1,460.44 |
DisclosureSEC source: 0001225208-12-025455 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2012 Filed Dec 4, 2012 00:31 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 58 | $25.02 | $1,451.16 |
DisclosureSEC source: 0001225208-12-024266 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2012 Filed Nov 19, 2012 13:33 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 58 | $23.66 | $1,372.28 |
DisclosureSEC source: 0001225208-12-023386 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.